Global Gastrointestinal Stromal Tumors Therapeutics Market Growth (Status and Outlook) 2022-2028
The global market for Gastrointestinal Stromal Tumors Therapeutics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Gastrointestinal Stromal Tumors Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Gastrointestinal Stromal Tumors Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Gastrointestinal Stromal Tumors Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Gastrointestinal Stromal Tumors Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Gastrointestinal Stromal Tumors Therapeutics players cover Ascentage Pharma Group International, Bayer AG, Blueprint Medicines Corp, Bristol Myers Squibb Co. and Deciphera Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Gastrointestinal Stromal Tumors Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Gastrointestinal Stromal Tumors Therapeutics market, with both quantitative and qualitative data, to help readers understand how the Gastrointestinal Stromal Tumors Therapeutics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Gastrointestinal Stromal Tumors Therapeutics market and forecasts the market size by Type (Oral and Non-oral,), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral
Non-oral
Segmentation by application
Hospital
Clinic
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Ascentage Pharma Group International
Bayer AG
Blueprint Medicines Corp
Bristol Myers Squibb Co.
Deciphera Pharmaceuticals Inc
Immunicum AB
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Xencor Inc.
Chapter Introduction
Chapter 1: Scope of Gastrointestinal Stromal Tumors Therapeutics, Research Methodology, etc.
Chapter 2: Executive Summary, global Gastrointestinal Stromal Tumors Therapeutics market size and CAGR, Gastrointestinal Stromal Tumors Therapeutics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Gastrointestinal Stromal Tumors Therapeutics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Gastrointestinal Stromal Tumors Therapeutics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Gastrointestinal Stromal Tumors Therapeutics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Ascentage Pharma Group International, Bayer AG, Blueprint Medicines Corp, Bristol Myers Squibb Co., Deciphera Pharmaceuticals Inc, Immunicum AB, Novartis AG, Pfizer Inc. and Sun Pharmaceutical Industries Ltd, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Market Size 2017-2028
2.1.2 Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gastrointestinal Stromal Tumors Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Non-oral
2.3 Gastrointestinal Stromal Tumors Therapeutics Market Size by Type
2.3.1 Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Gastrointestinal Stromal Tumors Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Gastrointestinal Stromal Tumors Therapeutics Market Size by Application
2.5.1 Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
3 Gastrointestinal Stromal Tumors Therapeutics Market Size by Player
3.1 Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Gastrointestinal Stromal Tumors Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gastrointestinal Stromal Tumors Therapeutics by Regions
4.1 Gastrointestinal Stromal Tumors Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Gastrointestinal Stromal Tumors Therapeutics Market Size Growth (2017-2022)
4.3 APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Growth (2017-2022)
4.4 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2017-2022)
5.2 Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022)
5.3 Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2017-2022)
6.2 APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022)
6.3 APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gastrointestinal Stromal Tumors Therapeutics by Country (2017-2022)
7.2 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022)
7.3 Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.1 Global Gastrointestinal Stromal Tumors Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Gastrointestinal Stromal Tumors Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Gastrointestinal Stromal Tumors Therapeutics Forecast
10.1.3 APAC Gastrointestinal Stromal Tumors Therapeutics Forecast
10.1.4 Europe Gastrointestinal Stromal Tumors Therapeutics Forecast
10.1.5 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Forecast
10.2 Americas Gastrointestinal Stromal Tumors Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.2.2 Canada Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.2.3 Mexico Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.2.4 Brazil Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3 APAC Gastrointestinal Stromal Tumors Therapeutics Forecast by Region (2023-2028)
10.3.1 China Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3.2 Japan Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3.3 Korea Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3.5 India Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.3.6 Australia Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.4 Europe Gastrointestinal Stromal Tumors Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.4.2 France Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.4.3 UK Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.4.4 Italy Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.4.5 Russia Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.5 Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.5.2 South Africa Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.5.3 Israel Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.5.4 Turkey Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.5.5 GCC Countries Gastrointestinal Stromal Tumors Therapeutics Market Forecast
10.6 Global Gastrointestinal Stromal Tumors Therapeutics Forecast by Type (2023-2028)
10.7 Global Gastrointestinal Stromal Tumors Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Ascentage Pharma Group International
11.1.1 Ascentage Pharma Group International Company Information
11.1.2 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.1.3 Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Ascentage Pharma Group International Main Business Overview
11.1.5 Ascentage Pharma Group International Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.2.3 Bayer AG Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 Blueprint Medicines Corp
11.3.1 Blueprint Medicines Corp Company Information
11.3.2 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.3.3 Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Blueprint Medicines Corp Main Business Overview
11.3.5 Blueprint Medicines Corp Latest Developments
11.4 Bristol Myers Squibb Co.
11.4.1 Bristol Myers Squibb Co. Company Information
11.4.2 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.4.3 Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol Myers Squibb Co. Main Business Overview
11.4.5 Bristol Myers Squibb Co. Latest Developments
11.5 Deciphera Pharmaceuticals Inc
11.5.1 Deciphera Pharmaceuticals Inc Company Information
11.5.2 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.5.3 Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Deciphera Pharmaceuticals Inc Main Business Overview
11.5.5 Deciphera Pharmaceuticals Inc Latest Developments
11.6 Immunicum AB
11.6.1 Immunicum AB Company Information
11.6.2 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.6.3 Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Immunicum AB Main Business Overview
11.6.5 Immunicum AB Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.7.3 Novartis AG Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Information
11.8.2 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.8.3 Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer Inc. Main Business Overview
11.8.5 Pfizer Inc. Latest Developments
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Sun Pharmaceutical Industries Ltd Company Information
11.9.2 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.9.3 Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sun Pharmaceutical Industries Ltd Main Business Overview
11.9.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.10 Xencor Inc.
11.10.1 Xencor Inc. Company Information
11.10.2 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Offered
11.10.3 Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Xencor Inc. Main Business Overview
11.10.5 Xencor Inc. Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Non-oral
Table 4. Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Gastrointestinal Stromal Tumors Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Gastrointestinal Stromal Tumors Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Gastrointestinal Stromal Tumors Therapeutics Key Players Head office and Products Offered
Table 13. Gastrointestinal Stromal Tumors Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Stromal Tumors Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumors Therapeutics
Table 43. Key Market Challenges & Risks of Gastrointestinal Stromal Tumors Therapeutics
Table 44. Key Industry Trends of Gastrointestinal Stromal Tumors Therapeutics
Table 45. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Ascentage Pharma Group International Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 52. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 53. Ascentage Pharma Group International Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Ascentage Pharma Group International Main Business
Table 55. Ascentage Pharma Group International Latest Developments
Table 56. Bayer AG Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 57. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 58. Bayer AG Main Business
Table 59. Bayer AG Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Bayer AG Latest Developments
Table 61. Blueprint Medicines Corp Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 62. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 63. Blueprint Medicines Corp Main Business
Table 64. Blueprint Medicines Corp Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Blueprint Medicines Corp Latest Developments
Table 66. Bristol Myers Squibb Co. Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 67. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 68. Bristol Myers Squibb Co. Main Business
Table 69. Bristol Myers Squibb Co. Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Bristol Myers Squibb Co. Latest Developments
Table 71. Deciphera Pharmaceuticals Inc Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 72. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 73. Deciphera Pharmaceuticals Inc Main Business
Table 74. Deciphera Pharmaceuticals Inc Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Deciphera Pharmaceuticals Inc Latest Developments
Table 76. Immunicum AB Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 77. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 78. Immunicum AB Main Business
Table 79. Immunicum AB Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Immunicum AB Latest Developments
Table 81. Novartis AG Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 82. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 83. Novartis AG Main Business
Table 84. Novartis AG Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Novartis AG Latest Developments
Table 86. Pfizer Inc. Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 87. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 88. Pfizer Inc. Main Business
Table 89. Pfizer Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Pfizer Inc. Latest Developments
Table 91. Sun Pharmaceutical Industries Ltd Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 92. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 93. Sun Pharmaceutical Industries Ltd Main Business
Table 94. Sun Pharmaceutical Industries Ltd Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sun Pharmaceutical Industries Ltd Latest Developments
Table 96. Xencor Inc. Details, Company Type, Gastrointestinal Stromal Tumors Therapeutics Area Served and Its Competitors
Table 97. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Product Offered
Table 98. Xencor Inc. Main Business
Table 99. Xencor Inc. Gastrointestinal Stromal Tumors Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Xencor Inc. Latest Developments
List of Figures
List of Figures
Figure 1. Gastrointestinal Stromal Tumors Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type in 2021
Figure 7. Gastrointestinal Stromal Tumors Therapeutics in Hospital
Figure 8. Global Gastrointestinal Stromal Tumors Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Gastrointestinal Stromal Tumors Therapeutics in Clinic
Figure 10. Global Gastrointestinal Stromal Tumors Therapeutics Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Gastrointestinal Stromal Tumors Therapeutics in Others
Figure 12. Global Gastrointestinal Stromal Tumors Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Gastrointestinal Stromal Tumors Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Gastrointestinal Stromal Tumors Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Gastrointestinal Stromal Tumors Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Gastrointestinal Stromal Tumors Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Gastrointestinal Stromal Tumors Therapeutics Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets